{
  "trial_id": "NCT02766582",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, performance status (ECOG), organ function, pregnancy status, stage of cancer, residual disease status, prior treatments, biopsy status, baseline laboratory values, childbearing potential, use of birth control methods, history of immunodeficiency, history of active TB, hypersensitivity to pembrolizumab, history of pneumonitis, additional malignancies, CNS metastases status, autoimmune disease status, infection status, psychiatric or substance abuse history, HIV status, Hepatitis B status, Hepatitis C status, history of receiving live vaccines.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "childbearing potential"
        ],
        [
          "Stage III and IV",
          "stage of cancer"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "performance status (ECOG)",
        "organ function",
        "pregnancy status",
        "residual disease status",
        "prior treatments",
        "biopsy status",
        "baseline laboratory values",
        "use of birth control methods",
        "history of immunodeficiency",
        "history of active TB",
        "hypersensitivity to pembrolizumab",
        "history of pneumonitis",
        "additional malignancies",
        "CNS metastases status",
        "autoimmune disease status",
        "infection status",
        "psychiatric or substance abuse history",
        "HIV status",
        "Hepatitis B status",
        "Hepatitis C status",
        "history of receiving live vaccines"
      ]
    },
    "processed-gen-response": "Age, performance status (ECOG), organ function, pregnancy status, stage of cancer, residual disease status, prior treatments, biopsy status, baseline laboratory values, childbearing potential, use of birth control methods, history of immunodeficiency, history of active TB, hypersensitivity to pembrolizumab, history of pneumonitis, additional malignancies, CNS metastases status, autoimmune disease status, infection status, psychiatric or substance abuse history, HIV status, Hepatitis B status, Hepatitis C status, history of receiving live vaccines."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, ECOG Performance Status, Stage of Cancer, Residual Disease Status, Organ Function (e.g., liver, kidney), Prior Cancer Treatments, Tumor Histology,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Stage III and IV",
          "Stage of Cancer"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Residual Disease Status",
        "Organ Function (e.g., liver, kidney)",
        "Prior Cancer Treatments",
        "Tumor Histology"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, ECOG Performance Status, Stage of Cancer, Residual Disease Status, Organ Function (e.g., liver, kidney), Prior Cancer Treatments, Tumor Histology"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, ECOG Performance Status, Histological subtype of ovarian cancer, Stage of disease, Residual disease after surgery, Prior chemotherapy or radiation therapy, Prior hormonal therapy, Prior surgery, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin, White Blood Cell Count, Platelet Count, Creatinine, Bilirubin, AST, ALT, Alkaline Phosphatase.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Stage III and IV",
          "Stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Histological subtype of ovarian cancer",
        "Residual disease after surgery",
        "Prior chemotherapy or radiation therapy",
        "Prior hormonal therapy",
        "Prior surgery",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Hemoglobin",
        "White Blood Cell Count",
        "Platelet Count",
        "Creatinine",
        "Bilirubin",
        "AST",
        "ALT",
        "Alkaline Phosphatase"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, ECOG Performance Status, Histological subtype of ovarian cancer, Stage of disease, Residual disease after surgery, Prior chemotherapy or radiation therapy, Prior hormonal therapy, Prior surgery, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin, White Blood Cell Count, Platelet Count, Creatinine, Bilirubin, AST, ALT, Alkaline Phosphatase."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, ECOG performance status, histological subtype of ovarian cancer, stage of disease, presence of residual disease, presence of measurable/macroscopic disease, prior surgery, prior chemotherapy, prior radiation therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Stage III and IV",
          "stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "ECOG performance status",
        "histological subtype of ovarian cancer",
        "presence of residual disease",
        "presence of measurable/macroscopic disease",
        "prior surgery",
        "prior chemotherapy",
        "prior radiation therapy"
      ]
    },
    "processed-gen-response": "age, sex, race, ethnicity, ECOG performance status, histological subtype of ovarian cancer, stage of disease, presence of residual disease, presence of measurable/macroscopic disease, prior surgery, prior chemotherapy, prior radiation therapy."
  }
}